Description

Piperazine, 1-(6,11-Dihydro-11-Phenyldibenzo(B,E)Thiepin-3-Yl)-4-Methyl-, (Z)-2-Butenedioate (1:1), Hydrate is a specialized pharmaceutical intermediate and active ingredient with a complex heterocyclic structure. This compound is valued for its precise chemical architecture, which is critical for advanced synthesis and research applications. It is primarily utilized by pharmaceutical R&D departments and fine chemical manufacturers engaged in the development of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of complex active pharmaceutical ingredients (APIs), particularly in central nervous system (CNS) and psychotropic drug research.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the development of new chemical entities.
• Fine Chemical Synthesis: Serves as a precursor for creating more complex molecules in custom synthesis and contract manufacturing.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and validation.
• Biochemical Research: Potential tool compound for investigating specific biological pathways and receptor interactions in preclinical studies.

Basic Information

Product Name	Piperazine, 1-(6,11-Dihydro-11-Phenyldibenzo(B,E)Thiepin-3-Yl)-4-Methyl-, (Z)-2-Butenedioate (1:1), Hydrate
CAS No.	84964-50-1
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	1-(6,11-Dihydro-11-phenyl-6H-dibenzo[b,e]thiepin-3-yl)-4-methylpiperazine maleate (1:1) hydrate; 1-(6,11-Dihydro-11-phenyldibenzo[b,e]thiepin-3-yl)-4-methylpiperazine maleate hydrate; 1-(6,11-Dihydro-11-phenyl-6H-dibenzo[b,e]thiepin-3-yl)-4-methylpiperazine (Z)-2-butenedioate (1:1) hydrate; 84964-50-1; Piperazine, 1-(6,11-dihydro-11-phenyldibenzo[b,e]thiepin-3-yl)-4-methyl-, (Z)-2-butenedioate (1:1), hydrate
EINECS	Contact for details

Quality Control

Our Piperazine, 1-(6,11-Dihydro-11-Phenyldibenzo(B,E)Thiepin-3-Yl)-4-Methyl-, (Z)-2-Butenedioate (1:1), Hydrate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting standards for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under dry conditions to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.